Application of Cardiac Molecular Imaging Using Positron Emission Tomography in Evaluation of Drug and Therapeutics for Cardiovascular Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|7|903-932

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.7, 2005-03, pp. : 903-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positron Emission Tomography in Drug Development and Drug Evaluation.

By  

Current Pharmaceutical Design, Vol. 6, Iss. 16, 2000-11 ,pp. : 1583-1591

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Positron Emission Tomography

By  

Heart Drug, Vol. 2, Iss. 3, 2002-07 ,pp. : 117-126

Karger

Access to resources Recommend Favorite

Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery

By  

Current Drug Targets, Vol. 16, Iss. 6, 2015-01 ,pp. : 610-624

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies for Non-Invasive Molecular Imaging of Acute Allograft Rejection by Gamma Scintigraphy and Positron Emission Tomography

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 1, 2011-01 ,pp. : 10-23

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Glucocorticoids as Molecular Probes for Imaging Brain Glucocorticoid Receptors by Means of Positron Emission Tomography (PET)

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 728-739

Bentham Science Publishers

Access to resources Recommend Favorite